Moffitt Selects Microsoft’s Azyxxi to Help Drive Personalized Cancer Treatment

Software to save years in research that aligns patients and treatments.

REDMOND, Wash., and TAMPA, Fla.— The H. Lee Moffitt Cancer Center & Research Institute has selected Azyxxi®, the Microsoft® unified health enterprise platform, to aid in its development of personalized cancer treatment programs. Azyxxi will be used to assimilate large quantities of diverse data, including electrocardiograms, magnetic resonance imaging scans, dynamic angiograms, ultrasound images and, ultimately, genomic information, providing a visual gateway for instant access to the information, and allowing researchers to make and prove their hypotheses within minutes instead of months.

“After searching for two years, we selected Azyxxi because we believe it provides the healthcare and research context that other products in the marketplace just don’t offer,” said Ed Martinez, chief information officer at Moffitt. “As a product developed by physicians, Azyxxi works the way clinicians and researchers work. It provides rapid results with minimum clicks, and allows for specific queries to help analyze and visualize data.”

Personalized medicine holds the promise to better align patients with treatment programs. Azyxxi will help in the mining of data that allows Moffitt to make appropriate clinical and scientific discoveries, setting the stage for relating genetic information to clinical practice.

“Azyxxi’s ability to correlate information and present it in a cohesive way can help any health organization tackle almost any challenge, and this is another great example of that,” said Peter Neupert, corporate vice president of the Health Solutions Group at Microsoft Corp. “We are thrilled that Moffitt recognizes Azyxxi as a tool that can help its researchers, clinicians — and ultimately patients — not only in the Moffitt Cancer Center but across the state of Florida.”